Pushing the limits of immune-related response: a case of “extreme pseudoprogression”

10.1007/s00262-018-2167-3

Saved in:

Bibliographic Details
Main Authors:	Wong, A.S, Thian, Y.-L, Kapur, J, Leong, C.-N, Kee, P, Lee, C.-T, Lee, M.B
Other Authors:	DIAGNOSTIC RADIOLOGY
Format:	Article
Published:	Springer Science and Business Media Deutschland GmbH 2020
Subjects:	alkaline phosphatase axitinib calcium creatinine denosumab everolimus gabapentin hemoglobin interleukin 2 lactate dehydrogenase nivolumab pazopanib prednisolone sunitinib tramadol antineoplastic agent monoclonal antibody programmed death 1 receptor acute kidney failure adult anemia antiangiogenic therapy Article backache bone metastasis brain metastasis calcium blood level cancer immunotherapy cancer palliative therapy cancer radiotherapy cancer regression case report clinical article computer assisted tomography creatinine blood level deterioration disease course drug dose reduction drug megadose dyspnea Eastern Cooperative Oncology Group score echography edema erythrocyte transfusion external beam radiotherapy extreme pseudoprogression functional status assessment general condition improvement hematuria hemodialysis hemolysis home care hospice care human hypercalcemia hyperkalemia immune related response criteria male middle aged oliguria oncogenesis and malignant transformation outcome assessment priority journal renal cell carcinoma response evaluation criteria in solid tumors side effect single drug dose spine metastasis systemic therapy terminal care thorax radiography treatment response tumor volume urine volume antagonists and inhibitors disease exacerbation immunology immunotherapy kidney tumor pathology Antibodies, Monoclonal Antineoplastic Agents Carcinoma, Renal Cell Disease Progression Humans Immunotherapy Kidney Neoplasms Male Middle Aged Programmed Cell Death 1 Receptor
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/179031
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-179031
record_format	dspace
spelling	sg-nus-scholar.10635-1790312024-04-24T05:53:08Z Pushing the limits of immune-related response: a case of “extreme pseudoprogression” Wong, A.S Thian, Y.-L Kapur, J Leong, C.-N Kee, P Lee, C.-T Lee, M.B DIAGNOSTIC RADIOLOGY MEDICINE alkaline phosphatase axitinib calcium creatinine denosumab everolimus gabapentin hemoglobin interleukin 2 lactate dehydrogenase nivolumab pazopanib prednisolone sunitinib tramadol antineoplastic agent monoclonal antibody nivolumab programmed death 1 receptor acute kidney failure adult anemia antiangiogenic therapy Article backache bone metastasis brain metastasis calcium blood level cancer immunotherapy cancer palliative therapy cancer radiotherapy cancer regression case report clinical article computer assisted tomography creatinine blood level deterioration disease course drug dose reduction drug megadose dyspnea Eastern Cooperative Oncology Group score echography edema erythrocyte transfusion external beam radiotherapy extreme pseudoprogression functional status assessment general condition improvement hematuria hemodialysis hemolysis home care hospice care human hypercalcemia hyperkalemia immune related response criteria male middle aged oliguria oncogenesis and malignant transformation outcome assessment priority journal renal cell carcinoma response evaluation criteria in solid tumors side effect single drug dose spine metastasis systemic therapy terminal care thorax radiography treatment response tumor volume urine volume antagonists and inhibitors disease exacerbation immunology immunotherapy kidney tumor pathology renal cell carcinoma Antibodies, Monoclonal Antineoplastic Agents Carcinoma, Renal Cell Disease Progression Humans Immunotherapy Kidney Neoplasms Male Middle Aged Programmed Cell Death 1 Receptor 10.1007/s00262-018-2167-3 Cancer Immunology, Immunotherapy 67 7 1105-1111 2020-10-22T07:23:05Z 2020-10-22T07:23:05Z 2018 Article Wong, A.S, Thian, Y.-L, Kapur, J, Leong, C.-N, Kee, P, Lee, C.-T, Lee, M.B (2018). Pushing the limits of immune-related response: a case of “extreme pseudoprogression”. Cancer Immunology, Immunotherapy 67 (7) : 1105-1111. ScholarBank@NUS Repository. https://doi.org/10.1007/s00262-018-2167-3 03407004 https://scholarbank.nus.edu.sg/handle/10635/179031 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Springer Science and Business Media Deutschland GmbH Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	alkaline phosphatase axitinib calcium creatinine denosumab everolimus gabapentin hemoglobin interleukin 2 lactate dehydrogenase nivolumab pazopanib prednisolone sunitinib tramadol antineoplastic agent monoclonal antibody nivolumab programmed death 1 receptor acute kidney failure adult anemia antiangiogenic therapy Article backache bone metastasis brain metastasis calcium blood level cancer immunotherapy cancer palliative therapy cancer radiotherapy cancer regression case report clinical article computer assisted tomography creatinine blood level deterioration disease course drug dose reduction drug megadose dyspnea Eastern Cooperative Oncology Group score echography edema erythrocyte transfusion external beam radiotherapy extreme pseudoprogression functional status assessment general condition improvement hematuria hemodialysis hemolysis home care hospice care human hypercalcemia hyperkalemia immune related response criteria male middle aged oliguria oncogenesis and malignant transformation outcome assessment priority journal renal cell carcinoma response evaluation criteria in solid tumors side effect single drug dose spine metastasis systemic therapy terminal care thorax radiography treatment response tumor volume urine volume antagonists and inhibitors disease exacerbation immunology immunotherapy kidney tumor pathology renal cell carcinoma Antibodies, Monoclonal Antineoplastic Agents Carcinoma, Renal Cell Disease Progression Humans Immunotherapy Kidney Neoplasms Male Middle Aged Programmed Cell Death 1 Receptor
spellingShingle	alkaline phosphatase axitinib calcium creatinine denosumab everolimus gabapentin hemoglobin interleukin 2 lactate dehydrogenase nivolumab pazopanib prednisolone sunitinib tramadol antineoplastic agent monoclonal antibody nivolumab programmed death 1 receptor acute kidney failure adult anemia antiangiogenic therapy Article backache bone metastasis brain metastasis calcium blood level cancer immunotherapy cancer palliative therapy cancer radiotherapy cancer regression case report clinical article computer assisted tomography creatinine blood level deterioration disease course drug dose reduction drug megadose dyspnea Eastern Cooperative Oncology Group score echography edema erythrocyte transfusion external beam radiotherapy extreme pseudoprogression functional status assessment general condition improvement hematuria hemodialysis hemolysis home care hospice care human hypercalcemia hyperkalemia immune related response criteria male middle aged oliguria oncogenesis and malignant transformation outcome assessment priority journal renal cell carcinoma response evaluation criteria in solid tumors side effect single drug dose spine metastasis systemic therapy terminal care thorax radiography treatment response tumor volume urine volume antagonists and inhibitors disease exacerbation immunology immunotherapy kidney tumor pathology renal cell carcinoma Antibodies, Monoclonal Antineoplastic Agents Carcinoma, Renal Cell Disease Progression Humans Immunotherapy Kidney Neoplasms Male Middle Aged Programmed Cell Death 1 Receptor Wong, A.S Thian, Y.-L Kapur, J Leong, C.-N Kee, P Lee, C.-T Lee, M.B Pushing the limits of immune-related response: a case of “extreme pseudoprogression”
description	10.1007/s00262-018-2167-3
author2	DIAGNOSTIC RADIOLOGY
author_facet	DIAGNOSTIC RADIOLOGY Wong, A.S Thian, Y.-L Kapur, J Leong, C.-N Kee, P Lee, C.-T Lee, M.B
format	Article
author	Wong, A.S Thian, Y.-L Kapur, J Leong, C.-N Kee, P Lee, C.-T Lee, M.B
author_sort	Wong, A.S
title	Pushing the limits of immune-related response: a case of “extreme pseudoprogression”
title_short	Pushing the limits of immune-related response: a case of “extreme pseudoprogression”
title_full	Pushing the limits of immune-related response: a case of “extreme pseudoprogression”
title_fullStr	Pushing the limits of immune-related response: a case of “extreme pseudoprogression”
title_full_unstemmed	Pushing the limits of immune-related response: a case of “extreme pseudoprogression”
title_sort	pushing the limits of immune-related response: a case of “extreme pseudoprogression”
publisher	Springer Science and Business Media Deutschland GmbH
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/179031
_version_	1800914533152194560

Pushing the limits of immune-related response: a case of “extreme pseudoprogression”

Similar Items